Andrew Berens
Stock Analyst at Leerink Partners
(1.12)
Main Sectors:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
CELC Celcuity | Maintains: Outperform | 28 60 | 46.7 | 28.48% | 2 | Jul 28, 2025 | |
COGT Cogent Biosciences | Maintains: Outperform | 16 18 | 10.93 | 64.68% | 5 | Jul 7, 2025 | |
NUVL Nuvalent | Maintains: Outperform | 125 140 | 74.98 | 86.72% | 2 | Jun 24, 2025 | |
ARVN Arvinas | Downgrades: Market Perform | 10 9 | 6.58 | 36.78% | 6 | Jun 2, 2025 | |
CMPX Compass Therapeutics | Upgrades: Outperform | 4 6 | 3.33 | 80.18% | 3 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 1 | n/a | n/a | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 33 | 2.03 | 1525.62% | 1 | Dec 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 10 25 | 12.45 | 100.8% | 10 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 74 96 | 120.57 | -20.38% | 1 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 60 56 | 35.1 | 59.54% | 11 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 5 3 | n/a | n/a | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Market Perform | 50 97 | 129.46 | -25.07% | 24 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 78 | 79.21 | -1.53% | 12 | Dec 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 78 58 | 58.7 | -1.19% | 7 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 13 10 | 9.1 | 0% | 2 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 35 48 | 64.6 | -25.7% | 5 | Apr 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 30 | 25.59 | 17.23% | 11 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 162 141 | 228.74 | -38.36% | 19 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 236 300 | 184.71 | 62.42% | 11 | Jan 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 37 28 | 9.64 | 190.46% | 3 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 78 79 | 74.09 | 6.63% | 12 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 27 | 1.4 | 1828.57% | 7 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 4 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 30 | 0.84 | 3471.43% | 4 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 69 | n/a | n/a | 4 | Aug 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 101 76 | n/a | n/a | 6 | Jun 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 25 23 | 20.01 | 14.94% | 5 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 25 | 7.09 | 252.61% | 3 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 40 | 6.82 | 486.51% | 1 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 28 | 4.07 | 587.96% | 1 | Nov 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 67 | 2.42 | 2668.6% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Market Perform | 20 | 4.18 | 378.47% | 1 | Oct 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 25 | 6.42 | 289.41% | 1 | Sep 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 12 16 | 1.47 | 988.44% | 5 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 4 3 | n/a | n/a | 6 | Nov 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Overweight | 2000 | 1.42 | 140745.07% | 2 | Sep 7, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 156 146 | 74.96 | 94.77% | 3 | Mar 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 102 18 | n/a | n/a | 2 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 75 50 | 19 | 163.16% | 5 | Sep 22, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 16 8 | 12.56 | -36.31% | 7 | Jul 14, 2017 |